Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Someone brought up yesterday the company's lack of hiring and investment in sales and marketing people. Seems that the company has been one step ahead of some all along.
Maybe not, but they now secured an executive with a track record of developing annual sales of over $130M. Show me another OTC company that has THAT! An executive who developed multiple million dollar marketing and sales programs for Pitney-Bowes and The Tweddle Group. Kind of coincides with what the revenue projections show after 3 years, wouldn't you say?
And the mentality of ALWAYS looking for the PPS to change misses the entire picture this company is putting together. SLOWLY and methodically.
He has had a documented dispute with Cheeky long before anyone had heard of RXSF.
You look back, and the company looks forward. Your grass roots approach to "analyzing" companies and progress has a place, there is no doubt about that. I respect a lot of your posts and I understand where a lot of your analysis is rooted, but frankly speaking, the fastest path to this company's growth is to raise the right kind of money, under the right non-dilutive terms, as has been revealed by the CEO. Once that money is raised, I foresee the company moving forward with development and sales with all of its products. In this case, the more money the company raises, the more likely it will be able to meet its projections. I get your approach, but the healthcare medical device market won't wait. The splash needs to be big and made now. Just a difference in approach and a respectful difference of opinion.
I am keeping everyone on a level playing field, just as you think you do, making sure the information being talked about is accurate, based on the disclosures or what can be reasonably read into from the disclosures. I am sure time will tell on this one, but in the meantime, when posters cherry pick bits and pieces, then attempt to hang their hats on those pits without looking at all the facts in the aggregate, that becomes a problem. I don't think this company fits into your organic, grass roots model, and if you haven't invested yet, then while some of your analysis is legit, the purposes of same are unclear, and sometimes your analysis is lopsided intentionally to push back those who are believers and supporters, and that says its personal. There is no right and wrong here based on emotional sentiment, everyone is entitled to their own emotions, but, as you all know, facts can be presented all sorts of ways, to paint all sorts of pictures. And sometimes, there is motive to focus on a fact that suits your emotional goals. We have all see that on both sides.
I was under the impression he was an investor. All these mental gymnastics is better put to use at school.
I understand your point, but I think pointing that out distracts from the purpose of the release, thats all. From what I understand, Talons distribution is greater than what was in RXSF's PR. Let's see who else licenses the technology. :)
All this speculation is great, but the aggregate of the releases tells a much bigger picture than worrying about the trading price and volume over the last month. If you have to measure the company by daily performances, I suggest you are in the wrong company or are relying on the wrong metrics. I am sure we will know soon what happened and why BMAK is still there. I am sure the CEO will fully disclose things and what steps she is taking to punish them all. Thats one good thing about having a woman running the company, she doesn't do well in the old boys OTC scam club. I am waiting for more news so I can see the vision of where the company is going and better, how they are doing it.
NO Clue at all.
Dave. How do you miss the point. You seem so focused on a reference in the PR about another companies distribution or product. I am wondering again your intentions here. That companies distribution and inner workings is irrelevant for the point of the PR. You may have missed the point because the actual point debunks your old contentions when you were pointing out the "old technology" and a 10 year old patent as if it had no value. Evidently it has much more value than you gave it credit for. Your focus on Talon's relationship with The Home Depot is very misplaced as it relates to RXSF. I am sure that company ha a much greater reach that hasn't been disclosed.
I am pretty sure the release had no intent to "tout" another companies distribution. The release was squarely focused on another company, run by a former IBM engineer, made this companies IP valuable outside of what the company itself was doing with it.
You are mixing apples and oranges. Thats based on an employment agreement. If you notice the Form 4's, they are all board members, so its safe to assume that they turned in their cash compensation for stock at market. Has nothing to do with Mrs. Yarde's employment compensation.
And those was done at market, not a 50% discount, that should have clued you in it was different compensation.
Obviously the company has something they needed, and were willing to pay for. I call that progress and revenues. And it has to start somewhere. Usually starts small and tends to expand out. Wouldn't be surprised if the extent and quality of future infringers increases in both size and reach. Like I said, its just starting out. 2016 is only 30 days old.
I see it as the company has yet to prove itself. I see that they have been careful to follow a crafted plan that is designed to slowly grow the company instead of making it an overnight success. I agree with YD (some of the time anyway) that past numbers don't support the hype. But as with all development stage companies, there is a trailing period from which growth tends to spurt. I believe if there was a company to capitalize on applying its technology to improve a market sector that continues to suffer billions in losses, and watching it slowly creeping itself into the market through various channels, the hype does tell a much different story than its prior financials. Its all about looking forward and growth, its not about looking over your shoulder at the past, except in the one case whereas its valuable to not repeat mistakes that hampered growth. Clean up the debt, secure the right financing and grow the company. Thats my vote.
Success can be measure in many different ways.
It's only categorized as "Award" for filing purposes. They were owed CASH at the end of the year and decided to take stock, at market, in satisfaction of the cash. In other words, they paid for those shares with cash. No difference than if the company paid them the cash, and they went out and purchased those shares in the open market. Either way, they paid "at market" price via a direct purchase from the company and they were all required to file Form 4's, which they did.
And just for absolute clarity, the members of the board of directors are paid a small cash fee at the end of each year for their service to the company. I looked at the filings and there is no contingent agreement that they can opt to take stock rather than the cash. Its obviously something they agreed to do, ostensibly, because they know things we don't and believe the stock may be worth much more than the $3.40 per share they paid for them. But because the original consideration was based on their "service" to the company, and the "cash" would be considered an "award" under the SEC definitions (but in the real world not really, because its more compensation for their service to the board), it has to be characterized as an award - so the stock in lieu of cash, carries that same definition.
HOKIE - Looks like you pretty much nailed it. But you left out one thing - despite all of these serious distractions, the company is forging ahead with all of its plans. I am sure we will be apprised of all developments going forward, as Lorraine has been transparent with everything.
The ownership in the company does not change. Having the registration of shares revoked is the least costly way to go private. They may have done this for several reasons. To save the costs of being public, to make an acquisition easier without all the regulatory hurdles, or simply to shut its doors. Who knows. But your shares are your shares, and you still own them
Only in your mind.
It does take some longer than others to actually understand the process of progression of this company. Eventually, you will get it. The release today has far deeper meaning to investment bankers looking at the company aside from whatever the company expects in revenues. Missed the big picture.
Running out of pyramid MLM members to buy....
Looks like that CEO knows technology - 30 years at IBM.
You can say and think whatever you want. But if you slander the company which you have done on social media, ..... Well, I warned you. GLTU.
GOARMY, just found out from company if you continue to slander the company on social media, they will go after you legally. You were warned.
Still up over 3 months from split - VERM
They are doing what they do. They are making a market and shorting. Everyone demanding news for a short bump - you don't think they are too?
But still up over 75% since R/S
You did, I was addressing the issue on relying upon that information and making a mountain out of a mole hill.
Here is how I understand that rule. The reason why 5% or greater shareholders are allowed to be given that information is solely because they have to report their trades and acquisitions. If a shareholder is a less than 5% shareholder, they can then trade on that news (such as day traders) and profit from it to the exclusion of other shareholders. Also, information provided by a TA presumes those numbers are not contested by the company. Thats why unless the company releases those numbers, they should't be relied upon. Its a strict violation that members of this board need to be aware of.
The company made public the issue of the improper conversions. It obvious it also has a legal dispute with its former TA, so ANY information provided by it, I would not rely on, legally or otherwise.
At the end of the day, the TA improperly released that information, and it appears thats more the reason why now they are not the companies TA. The burden is on the TA to qualify the requestor as authorized.
There's a big difference between if and when. The company stated they did not expect it and it was improper. So just wait for the lawsuit. Besides, the company has no obligation to constantly update the market about its share structure. That's for day traders to worry about. So much so they improperly obtained information from the company's former transfer agent. It's a serious violation under Rule 10(b)-5.
I agree with that, but the trouble is the company does not know yet. Lorraine said that the company hired a new TA, and all of the files are in the process of being moved to the new TA, and the new TA needs to reconcile whats outstanding, and how it got there. I am sure once she knows, we will know.
I also think Hokie is basing his investment on the companies technology, some of its innovative products, the problems that those address and the size of the market as well. While some of those press releases are the intentions that the company believes it can achieve, well....as long as they secure the funding, time will tell. To say the definitely will, or definitely won't, is premature. But I would assume people here invest on risk of high reward, so we will see what the company does these next two quarters both in terms of productivity and market awareness.
Dave, I agree with most of your analysis. I am sure once the company gets a total from its new TA, or the suit is filed, whichever is sooner, it will reveal exactly what happened. But we are talking a difference in what appears in the market, to be 20,000 shares that may or may not have been part of the MM's short play. Either way, I would guess the float is about 320K shares or about right now. While based on the public float count, its less than 10% of the public float and minuscule compared with outstanding, not saying that isn't a lot, but its not enough to jump off that cliff that everyone else seems to be pushing the company towards. Yea, its an unfortunate situation that the day traders (not the longs) are pounding into the earth because they live and die by short swings, but you and I both know things like this happen in business, and its up to leadership to get to the bottom of it, and disclose it when they know.
At least we know the damage is limited, and with a 320K share float, this is easily corrected with a little more production and visibility by the company.
They aren't. Its a mentality - grab the money now, and deal with the consequences later. The company will probably get FINRA involved also since FINRA regulates the broker and TA. They will straighten this out.
How about still up 75% after announcing the split back in October, thats 4 MONTHS!!!! Even with all this BS?
You call the trip pennies you hype "good" "robust" and "worthy Investments" ROFLMAO!
The company announced a program over the summer to target that market. Your instincts are good.
Safes that were sold in 2010-2012 to families with teenagers, are now in some of those teenagers dorm rooms. Mine included. Prescription drug theft is a HUGE problem on college campuses.
The problem with the that mentality is that it is NOT geared to holding long and riding through the dips and bumps. Its designed to leverage, guess, try to find any information that would provide a scintilla of proof that the stock will be going up or down, and then trade on that. Period. This CEO has been very transparent, but it seems she is not moving fast enough for some - come back in 6 months then. At this stage, IMHO, her ONLY focus right now should be to raise the money needed to achieve the successes she expects while inching through new sales programs. I want her dedicating ALL her time looking for, and securing money, because once that is done, the game is over IMHO. She is again, telegraphing what she is doing, and more importantly, whom she is doing it with. The only trouble is the typical short mentality, trading on news. So the stock drops 33% on 1000 shares traded. But the stock also shot to $7.50 on 10,000 shares traded. See CANT, they are waiting - Cantor Fitzgerald is not a shorter MM, its a reputable firm. They don't show up on the box unless they have a trade order (buy or sell), or they have a feeling something is coming after absorbing the transparency of this company.
Really, if you want this company to break out tomorrow, then you might as well sell and go away. It takes a long time, especially without the financial resources to drive the company forward. If you like the company's products, the markets it serves, and the underlying purpose of its products, then make a decision, but stop complaining every single day if the stock isn't immediately meeting your expectations. Its still up over 100% since the split last month. Most stocks crumble down to nothing within a week or 2 after the reverse. You should be able to piece together the bigger picture from the news.
As far as interest, how do we know what the interest is? When a company presents at an investment conference event, it generates interest - The attendee's at the JP Morgan event are very sophisticated investment banks and are NOT allowed to go trade into the stock based upon those presentations. The type of interest thats generated is the level of follow up - when those IB's seek the company out to express an intent to invest in. Its not a cheap OTC IR luncheon with brokers and traders where they get free lunch, and booze which mostly are designed for a quick pump. Its sophisticated Wall Street investors who go back, look at their portfolio companies, analyze the market, and do its DD on the company before even reaching back out. That takes time. I like this company, believe the CEO is grounded in reality and is transparent, and I believe she is that way whether you are a day trader to the director of a big institutional lender. She will treat them equally.
Probably because thats a real bid, not a pure MM generated one, and not sure what to do with it. If they sell him shares, do they have them to fill? Maybe they don;t want to fill at higher than last trade because it screws up their math. Either way, you have to give credit to YD - he is a mensch - and trying to help.
Also very smart.